SAB Biotherapeutics, Inc. (SABS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for SAB Biotherapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 5.44x | -1.03x | -0.90x | -1.37x | -19.80x | 21.93x |
| P/B Ratio | 0.48x | 1.35x | 0.66x | 0.83x | 8.81x | 11.31x |
| P/S Ratio | 0.00x | 26.54x | 16.96x | 1.07x | 5.58x | 7.99x |
| Profitability | ||||||
| Gross Margin | 0.0% | -262.4% | -67.3% | 86.2% | 97.3% | 100.0% |
| Operating Margin | 0.0% | -3244.9% | -1700.5% | -121.0% | -22.0% | 37.2% |
| Net Margin | 0.0% | -2579.0% | -1884.5% | -78.4% | -28.2% | 36.4% |
| EBITDA Margin | 0.0% | -2192.5% | -1703.1% | -63.3% | -25.0% | 38.3% |
| Liquidity | ||||||
| Current Ratio | 9.46x | 2.98x | 5.45x | 1.47x | 1.90x | 3.11x |
| Quick Ratio | 9.46x | 2.98x | 5.45x | 1.47x | 1.90x | 3.11x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.18x | 0.10x | 0.19x | 0.22x | 0.21x |
YoY = year-over-year change. Source: FMP..